myriad genetics stock analysis

Barrons Myriad Genetics Stock Is Tanking After Earnings. Exclusive research and insights from bulls and bears.

Mygn Stock Price And Chart Nasdaq Mygn Tradingview

ET by Tomi Kilgore.

. Myriad Genetics Inc. On average they expect Myriad Genetics share price. MYGN stock analyst estimates including earnings and revenue EPS upgrades and downgrades.

MYRIAD GENETICS INC. See Myriad Genetics Inc. Myriad Genetics MYGN - DEVELOPS.

The firm has a market capitalization of 180 billion a PE ratio of -18642 and a beta of 157. 6 2020 at 636 am. Free Stock Analysis Report Myriad Genetics Inc.

MYGN Myriad Genetics - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. Find the latest analyst research for Myriad Genetics Inc. Our outlook to estimating the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified awayWe have found twenty-one.

Technical Analysis Summary for Myriad Genetics Inc with Moving Average Stochastics MACD RSI Average Volume. Myriad Genetics Inc a genetic testing and precision medicine company develops and commercializes genetic tests in the United States and. Free Stock Analysis Report BioRad Laboratories Inc.

Free Stock Analysis Report Myriad Genetics Inc. MYGN stock analysis from Seeking Alphas top analysts. The Company primarily provides testing and collaborative.

Click to get this free report McKesson Corporation MCK. 117 Myriad Genetics Inc. Myriad Genetics to Release First-Quarter 2022 Financial Results on May 5 2022.

Learn about Myriad Genetics Inc MYGNXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and. Find the latest Myriad Genetics Inc. Over the past year the Zacks Rank 3 Hold stock has lost 161 compared with the 379 decline of the industry and 9 rise of the SP 500.

Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance Dividends. 3 analysts have issued twelve-month target prices for Myriad Genetics stock. Free Stock Analysis Report Moderna Inc.

MYGN stock is trading at 2265 as of 400 PM on Tuesday May 17 an increase of 064 or 291 from the previous closing price of 2201. Free Stock Analysis Report Myriad Genetics Inc. The CEO Is Out.

SALT LAKE CITY April 28 2022 GLOBE NEWSWIRE -- Myriad Genetics Inc NASDAQ. Real time Myriad Genetics MYGN stock price quote stock graph news analysis. MYGN Myriad Genetics Inc.

Their forecasts range from 2300 to 3500. InvestorsObserver gives Myriad Genetics Inc MYGN an overall rank of 38 which is below average. Is a genetic testing and precision medicine company.

Myriad Genetics stock price target cut to 14 from 17 at JP. Myriad Genetics Inc is in the bottom half of stocks based on the. Click to get this free report Vertex Pharmaceuticals Incorporated VRTX.

Myriad Genetics Inc MYD.

Myriad Genetics Inc Nasdaq Mygn Just Released Its Full Year Results And Analysts Are Updating Their Estimates